BIOMAT Database Logo BIOMAT Database Logo

Rapid detection of Staphylococcus aureus Panton-Valentine leukocidin in clinical specimens by enzyme-linked immunosorbent assay and immunochromatographic tests. 2010

Cedric Badiou, and Oana Dumitrescu, and Narelle George, and Andrea R N Forbes, and Eleanna Drougka, and Kian Sing Chan, and Nadjia Ramdani-Bouguessa, and Helene Meugnier, and Michele Bes, and Francois Vandenesch, and Jerome Etienne, and Li Yang Hsu, and Mohamed Tazir, and Iris Spiliopoulou, and Graeme R Nimmo, and Kristina G Hulten, and Gerard Lina
Université Lyon 1, Centre National de Référence des Staphylocoques, Lyon.

Staphylococcus aureus strains producing Panton-Valentine leukocidin (PVL) have been epidemiologically linked to specific human infections. To evaluate immunological tests that may be used to diagnose infections with PVL-producing strains, we prospectively collected pus, respiratory tract specimens, and joint fluid specimens from which S. aureus had been isolated in clinical laboratories in six countries. An enzyme-linked immunosorbent assay (ELISA) and an immunochromatographic test (ICT) targeting LukS-PV were performed directly with clinical samples for the detection of PVL. The same tests were applied to S. aureus culture supernatants. The corresponding S. aureus isolates were characterized by PCR for the presence of the PVL locus (lukS-PV and lukF-PV) and the mecA gene. A total of 185 samples from 144 skin infections, 23 bone and joint infections, and 18 lower respiratory tract infections were analyzed. By PCR, 72/185 S. aureus isolates were PVL locus positive (PVL(+)); 28 of these were also mecA positive. PVL was detected in the supernatants of all PVL(+) strains by both ELISA and an ICT, while no signal was observed with PVL-negative strains. The PVL concentrations in human clinical samples that grew PVL(+) strains ranged from 0 to 399 microg/ml by ELISA. By the use of 0.015 microg/ml of PVL as a cutoff value, PVL was detected in 65/72 (90%) of the clinical samples by ELISA. The sensitivity and specificity of the ELISA test were 90% and 100%, respectively. By the ICT, PVL was detected in 57/72 (79%) of the samples, and the sensitivity and specificity of ICT were 79% and 100%, respectively. PVL is expressed by S. aureus during human infection, and a PVL-specific ELISA and ICT could be reliable tests for the diagnosis of infections caused by PVL-producing strains.

UI MeSH Term Description Entries
D007118 Immunoassay A technique using antibodies for identifying or quantifying a substance. Usually the substance being studied serves as antigen both in antibody production and in measurement of antibody by the test substance. Immunochromatographic Assay,Assay, Immunochromatographic,Assays, Immunochromatographic,Immunoassays,Immunochromatographic Assays
D007956 Leukocidins Pore forming proteins originally discovered for toxic activity to LEUKOCYTES. They are EXOTOXINS produced by some pathogenic STAPHYLOCOCCUS and STREPTOCOCCUS that destroy leukocytes by lysis of the cytoplasmic granules and are partially responsible for the pathogenicity of the organisms. Leucocidin,Leukocidin,Leukocidin Proteins,Proteins, Leukocidin
D004269 DNA, Bacterial Deoxyribonucleic acid that makes up the genetic material of bacteria. Bacterial DNA
D005098 Exotoxins Toxins produced, especially by bacterial or fungal cells, and released into the culture medium or environment. Exotoxin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial
D001427 Bacterial Toxins Toxic substances formed in or elaborated by bacteria; they are usually proteins with high molecular weight and antigenicity; some are used as antibiotics and some to skin test for the presence of or susceptibility to certain diseases. Bacterial Toxin,Toxins, Bacterial,Toxin, Bacterial
D001431 Bacteriological Techniques Techniques used in studying bacteria. Bacteriologic Technic,Bacteriologic Technics,Bacteriologic Techniques,Bacteriological Technique,Technic, Bacteriological,Technics, Bacteriological,Technique, Bacteriological,Techniques, Bacteriological,Bacteriologic Technique,Bacteriological Technic,Bacteriological Technics,Technic, Bacteriologic,Technics, Bacteriologic,Technique, Bacteriologic,Techniques, Bacteriologic
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D013203 Staphylococcal Infections Infections with bacteria of the genus STAPHYLOCOCCUS. Infections, Staphylococcal,Staphylococcus aureus Infection,Staphylococcal Infection,Staphylococcus aureus Infections

Related Publications

Cedric Badiou, and Oana Dumitrescu, and Narelle George, and Andrea R N Forbes, and Eleanna Drougka, and Kian Sing Chan, and Nadjia Ramdani-Bouguessa, and Helene Meugnier, and Michele Bes, and Francois Vandenesch, and Jerome Etienne, and Li Yang Hsu, and Mohamed Tazir, and Iris Spiliopoulou, and Graeme R Nimmo, and Kristina G Hulten, and Gerard Lina
Panton-Valentine leukocidin-producing Staphylococcus aureus.
November 2006, Emerging infectious diseases,
Cedric Badiou, and Oana Dumitrescu, and Narelle George, and Andrea R N Forbes, and Eleanna Drougka, and Kian Sing Chan, and Nadjia Ramdani-Bouguessa, and Helene Meugnier, and Michele Bes, and Francois Vandenesch, and Jerome Etienne, and Li Yang Hsu, and Mohamed Tazir, and Iris Spiliopoulou, and Graeme R Nimmo, and Kristina G Hulten, and Gerard Lina
Panton-Valentine leukocidin genes in Staphylococcus aureus.
July 2006, Emerging infectious diseases,
Cedric Badiou, and Oana Dumitrescu, and Narelle George, and Andrea R N Forbes, and Eleanna Drougka, and Kian Sing Chan, and Nadjia Ramdani-Bouguessa, and Helene Meugnier, and Michele Bes, and Francois Vandenesch, and Jerome Etienne, and Li Yang Hsu, and Mohamed Tazir, and Iris Spiliopoulou, and Graeme R Nimmo, and Kristina G Hulten, and Gerard Lina
Panton-Valentine leukocidin-positive Staphylococcus aureus, Singapore.
August 2004, Emerging infectious diseases,
Cedric Badiou, and Oana Dumitrescu, and Narelle George, and Andrea R N Forbes, and Eleanna Drougka, and Kian Sing Chan, and Nadjia Ramdani-Bouguessa, and Helene Meugnier, and Michele Bes, and Francois Vandenesch, and Jerome Etienne, and Li Yang Hsu, and Mohamed Tazir, and Iris Spiliopoulou, and Graeme R Nimmo, and Kristina G Hulten, and Gerard Lina
Rapid detection of Panton-Valentine leukocidin from clinical isolates of Staphylococcus aureus strains by real-time PCR.
November 2004, FEMS microbiology letters,
Cedric Badiou, and Oana Dumitrescu, and Narelle George, and Andrea R N Forbes, and Eleanna Drougka, and Kian Sing Chan, and Nadjia Ramdani-Bouguessa, and Helene Meugnier, and Michele Bes, and Francois Vandenesch, and Jerome Etienne, and Li Yang Hsu, and Mohamed Tazir, and Iris Spiliopoulou, and Graeme R Nimmo, and Kristina G Hulten, and Gerard Lina
[Staphylococcus aureus producing Panton-Valentine leukocidin : notions in clinical practice].
October 2018, Revue medicale suisse,
Cedric Badiou, and Oana Dumitrescu, and Narelle George, and Andrea R N Forbes, and Eleanna Drougka, and Kian Sing Chan, and Nadjia Ramdani-Bouguessa, and Helene Meugnier, and Michele Bes, and Francois Vandenesch, and Jerome Etienne, and Li Yang Hsu, and Mohamed Tazir, and Iris Spiliopoulou, and Graeme R Nimmo, and Kristina G Hulten, and Gerard Lina
Staphylococcus aureus, Panton-Valentine leukocidin, and necrotising pneumonia.
October 2005, BMJ (Clinical research ed.),
Cedric Badiou, and Oana Dumitrescu, and Narelle George, and Andrea R N Forbes, and Eleanna Drougka, and Kian Sing Chan, and Nadjia Ramdani-Bouguessa, and Helene Meugnier, and Michele Bes, and Francois Vandenesch, and Jerome Etienne, and Li Yang Hsu, and Mohamed Tazir, and Iris Spiliopoulou, and Graeme R Nimmo, and Kristina G Hulten, and Gerard Lina
Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia.
February 2007, Science (New York, N.Y.),
Cedric Badiou, and Oana Dumitrescu, and Narelle George, and Andrea R N Forbes, and Eleanna Drougka, and Kian Sing Chan, and Nadjia Ramdani-Bouguessa, and Helene Meugnier, and Michele Bes, and Francois Vandenesch, and Jerome Etienne, and Li Yang Hsu, and Mohamed Tazir, and Iris Spiliopoulou, and Graeme R Nimmo, and Kristina G Hulten, and Gerard Lina
Panton-Valentine leukocidin-positive Staphylococcus aureus skin infections.
May 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Cedric Badiou, and Oana Dumitrescu, and Narelle George, and Andrea R N Forbes, and Eleanna Drougka, and Kian Sing Chan, and Nadjia Ramdani-Bouguessa, and Helene Meugnier, and Michele Bes, and Francois Vandenesch, and Jerome Etienne, and Li Yang Hsu, and Mohamed Tazir, and Iris Spiliopoulou, and Graeme R Nimmo, and Kristina G Hulten, and Gerard Lina
Detection of Panton-Valentine leukocidin gene in Staphylococcus aureus by LightCycler PCR: clinical and epidemiological aspects.
October 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
Cedric Badiou, and Oana Dumitrescu, and Narelle George, and Andrea R N Forbes, and Eleanna Drougka, and Kian Sing Chan, and Nadjia Ramdani-Bouguessa, and Helene Meugnier, and Michele Bes, and Francois Vandenesch, and Jerome Etienne, and Li Yang Hsu, and Mohamed Tazir, and Iris Spiliopoulou, and Graeme R Nimmo, and Kristina G Hulten, and Gerard Lina
Panton-valentine leukocidin-positive Staphylococcus aureus and foreign travel.
February 2008, Journal of clinical microbiology,
Copied contents to your clipboard!